Aurobindo Pharma Gets USFDA Approval for HIV Drug
November 29, 2023 12:54
Aurobindo Pharma receives USFDA approval to market a generic HIV-1 treatment drug, Darunavir tablets, in strengths of 600 mg and 800 mg. The drug is therapeutically equivalent to Prezista tablets.